A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors

U Bhardwaj, F Papadimitrakopoulos… - Journal of diabetes …, 2008 - journals.sagepub.com
A major obstacle to the development of implantable biosensors is the foreign body response
(FBR) that results from tissue trauma during implantation and the continuous presence of the …

Inflammatory markers and restenosis in peripheral percutaneous angioplasty with intravascular stenting: current concepts

EE Joviliano, CE Piccinato… - Annals of vascular …, 2011 - Elsevier
In this article, we review the current status of inflammation linked to percutaneous
transluminal angioplasty with stent implantation, especially as it relates to restenosis and its …

Relationship between Lp-PLA2 and in-stent restenosis after coronary stenting: a 3-year follow-up study

G Sheng, J Zhou, C Zhang, C Wu… - Scottish Medical …, 2021 - journals.sagepub.com
Background and aims Coronary in-stent restenosis (ISR) is an important complication of
percutaneous coronary intervention (PCI). However, the relationship between lipoprotein …

Inflammatory response, drug-eluting stent and restenosis

J Li - Chinese medical journal, 2008 - journals.lww.com
C ardiovascular diseases are the major cause of mortality in the Western world and it is
expected that this will remain so during the foreseeable future. 1 Among them, coronary …

[HTML][HTML] Tormentic acid reduces vascular smooth muscle cell proliferation and survival

AS Fogo, E Antonioli, JB Calixto, AH Campos - European Journal of …, 2009 - Elsevier
The triterpene tormentic acid (TA) has been reported to exhibit anticancer, anti-inflammatory
and anti-atherogenic properties, and minimal toxicity has been detected in in vivo. Vascular …

[HTML][HTML] Combination coating of chitosan and anti-CD34 antibody applied on sirolimus-eluting stents can promote endothelialization while reducing neointimal …

F Yang, SC Feng, XJ Pang, WX Li, YH Bi… - BMC Cardiovascular …, 2012 - Springer
Background Circulating endothelial progenitor cells (EPCs) capture technology improves
endothelialization rates of sirolimus-eluting stents (SES), but the problem of delayed re …

Comparison of changes in early inflammatory markers between sirolimus-and paclitaxel-eluting stent implantation

JJ Li, HB Yan, XP Xiang, XW Qin, CY Zhang - Cardiovascular drugs and …, 2009 - Springer
Background Systemic inflammation after coronary intervention identifies patients at
increased risk of subsequent cardiac events. Cardiac events, especially in-stent restenosis …

Comparison of inflammatory response after implantation of sirolimus-and paclitaxel-eluting stents in patients on hemodialysis

H Yano, S Horinaka, H Yagi, T Ishimitsu - Heart and vessels, 2013 - Springer
Because systemic inflammation after coronary intervention places patients at increased risk
of subsequent cardiac events, we aimed to compare clinical outcomes and chronic serum …

[PDF][PDF] 健康小型猪冠状动脉支架置入术后血管壁炎症反应与新生内膜增生的关系

罗彤, 高润霖, 阮英茆, 邱洪, 褚雁… - 中国医学 …, 2009 - journal13.magtechjournal.com
目的探讨小型猪冠状动脉支架置入术后血管壁炎症反应与新生内膜增生的关系. 方法20
只健康小型猪随机分入A 组(L316 不锈钢裸金属支架组), B 组(605L 钴铬合金裸金属支架组), C …

[HTML][HTML] Anti-inflammatory effects of arsenic trioxide eluting stents in a porcine coronary model

L Shen, F Gong, W Tian, W Li, F Zhang… - BioMed Research …, 2013 - hindawi.com
Previous research from our group has demonstrated arsenic trioxide eluting stents
significantly reduced neointimal area and thickness compared with bare metal stents. In the …